StonvexLoading…
StonvexStonvexStonvexCore line items from NPCE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $99.99M | $79.91M | $65.42M | $45.52M |
Operating Income | $-16.34M | $-21.67M | $-27.17M | $-40.79M |
Net Income | $-21.46M | $-27.14M | $-32.96M | $-47.08M |
EPS (Diluted) | $-0.66 | $-0.93 | $-1.27 | $-1.91 |
Total Assets | $105.56M | $94.65M | $107.65M | $114.11M |
Total Liabilities | $86.53M | $86.63M | $87.00M | $79.33M |
Cash & Equivalents | $21.69M | $13.43M | $18.06M | $6.61M |
Free Cash Flow OCF − CapEx | $-11.34M | $-18.25M | $-19.87M | $-37.47M |
Shares Outstanding | 33.57M | 30.15M | 27.82M | 25.05M |